These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15828493)

  • 1. Programmable elution profile coating for drug eluting stents.
    Al-Lamee K
    Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff.
    Pires NM; van der Hoeven BL; de Vries MR; Havekes LM; van Vlijmen BJ; Hennink WE; Quax PH; Jukema JW
    Biomaterials; 2005 Sep; 26(26):5386-94. PubMed ID: 15814137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents, restenosis and revascularization.
    Ramcharitar S; Gaster AL; Daemen J; Serruys P
    Herz; 2007 Jun; 32(4):287-95. PubMed ID: 17607535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
    Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
    Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
    Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
    Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial stents as a therapeutic platform.
    Roitberg B
    Surg Neurol; 2003 Mar; 59(3):146-7. PubMed ID: 12693402
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
    Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
    Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary stents: a materials perspective.
    Mani G; Feldman MD; Patel D; Agrawal CM
    Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Nordic Bifurcation Study. Randomized study on the question of optimal stenting technique for bifurcating stenosis].
    Herz; 2006 May; 31(3):257. PubMed ID: 17431944
    [No Abstract]   [Full Text] [Related]  

  • 10. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular pathology of drug-eluting stents.
    Nakazawa G; Finn AV; Virmani R
    Herz; 2007 Jun; 32(4):274-80. PubMed ID: 17607533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioscopic findings after drug-eluting stent implantation.
    Takano M; Mizuno K
    Herz; 2007 Jun; 32(4):281-6. PubMed ID: 17607534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General patterns and asymptotic dose in the design of coated stents.
    Bourgeois E; Delfour MC
    Comput Methods Biomech Biomed Engin; 2008 Aug; 11(4):323-34. PubMed ID: 18568828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.
    Boam AB
    Expert Rev Med Devices; 2006 May; 3(3):297-300. PubMed ID: 16681451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radionuclides-hyaluronan-conjugate thromboresistant coatings to prevent in-stent restenosis.
    Thierry B; Winnik FM; Merhi Y; Silver J; Tabrizian M
    Biomaterials; 2004 Aug; 25(17):3895-905. PubMed ID: 15020166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Position paper on the use of drug eluting stents in coronary heart disease].
    Mudra H; Bode C; Grube E; de Haan F; Levenson B; Schuler G; Silber S; ;
    Z Kardiol; 2004 May; 93(5):416-22. PubMed ID: 15160279
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug eluting stents and anticoagulation in the perioperative setting - an interdisciplinary challenge].
    Preckel B; Schlack W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Sep; 43(9):596-601. PubMed ID: 18792862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of ink-jet technology for the coating and loading of drug-eluting stents.
    Tarcha PJ; Verlee D; Hui HW; Setesak J; Antohe B; Radulescu D; Wallace D
    Ann Biomed Eng; 2007 Oct; 35(10):1791-9. PubMed ID: 17638081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents: from evidence to policy.
    Marchetti M
    Expert Rev Med Devices; 2004 Sep; 1(1):49-63. PubMed ID: 16293010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.